Search Results - robert+chanock+(estate)

4 Results Sort By:
Full-Length Infectious cDNA Clones of Tick Borne Flavivirus
The tick-borne encephalitis virus complex of flavivirus family includes tick-borne encephalitis (TBEV), Kyasanur forest disease, Langat, Louping ill, Negishi, Omsk hemorrhagic fever and Povassan viruses. These viruses are endemic throughout most of the Northern Hemisphere and except for Langat, cause human disease of varying severity that can have...
Published: 10/28/2024   |   Inventor(s): Robert Chanock (Estate), Alexander Pletnev
Keywords(s): Borne, cDNA, CLONES, DC5BXX, DC5XXX, DCXXXX, DXXXXX, Flavivirus, FULL-LENGTH, Hemorrhagic fever, INFECTIOUS, Omsk hemorrhagic fever, Patent Category - Biotechnology, Q fever, SACGHS DNA Patent Initial Set, TICK, Tick-borne encephalitis, UAXXXX
Category(s): Collaboration Sought > Licensing, Application > Vaccines, TherapeuticArea > Infectious Disease, TherapeuticArea > Rare / Neglected Diseases
Neutralizing Monoclonal Antibodies to Respiratory Syncytial Virus
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and pneumonia among infants and children under 1 year of age. Illness begins most frequently with fever, runny nose, cough, and sometimes wheezing. During their first RSV infection, between 25% and 40% of infants and young children have signs or symptoms of bronchiolitis or...
Published: 10/28/2024   |   Inventor(s): Robert Chanock (Estate), Brian Murphy, James Crowe
Keywords(s): antibodies, DB4BXX, DB4XXX, DBXXXX, DXXXXX, monoclonal, Neutralizing, Q fever, respiratory, Syncytial, virus
Category(s): Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Infectious Disease
Live Attenuated Vaccine to Prevent Disease Caused by West Nile Virus
West Nile virus (WNV) has recently emerged in the U.S. and is considered a significant emerging disease that has embedded itself over a considerable region of the U.S. WNV infections have been recorded in humans as well as in different animals. From 1999-2014, WNV killed 1,765 people in the U.S. and caused severe disease in more than 41,762 others....
Published: 10/28/2024   |   Inventor(s): Robert Chanock (Estate), Joseph Putnak, Brian Murphy, Joseph Blaney, Stephen Whitehead, Alexander Pletnev
Keywords(s): Chimeras, DC5BXX, DC5XXX, DCXXXX, DENGUE, Dengue (Flaviviridae), DXXXXX, Live, Nile, Vaccine, virus, VLXXXX, VOXXXX, WAXXXX, WBXXXX, West, WEST NILE VIRUS, WMXXXX, WNXXXX, XKXXXX, YCXXXX, YDXXXX
Category(s): Collaboration Sought > Licensing, TherapeuticArea > Infectious Disease, Application > Therapeutics, Application > Vaccines, Application > Consumer Products, Application > Diagnostics
Murine Monoclonal Antibodies Effective To Treat Respiratory Syncytial Virus
Available for licensing through a Biological Materials License Agreement are the murine MAbs described in Beeler et al, "Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function," J Virol. 1989 Jul;63(7):2941-2950 (PubMed abs). The MAbs that are available for licensing are the following:...
Published: 10/28/2024   |   Inventor(s): Peter Collins, Kathleen Coelingh, Robert Chanock (Estate), Brian Murphy, Judith Beeler
Keywords(s): #s, 1107;, 1112;, 1121;, 1129;, 1142;, 1153;, 1175-40; 1113-44; 1105-1, 1200;, 1214;, 1269, Cell, DB4BXX, DBXXXX, DXXXXX, Hybridoma, Lines, monoclonal
Category(s): Collaboration Sought > Licensing, Collaboration Sought > Materials Available, Application > Therapeutics, TherapeuticArea > Infectious Disease